Ibuprofen

Active ingredient description

Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Ibuprofen
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB16
Ibuprofen
G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CC Antiinflammatory products for vaginal administration
Discover more medicines within G02CC01
Ibuprofen
M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE01
Ibuprofen
M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA13

Medicines

Ibuprofen is the active ingredient of these drugs:

Drug
Countries

Lithuania

Ireland

South Africa

Austria

Brazil Canada France Hong Kong Netherlands

Ecuador

Ecuador

Austria Germany

Spain

Spain

Cyprus

Italy

Cyprus

Brazil

Spain

Brazil

Hong Kong

United Kingdom

United Kingdom

United Kingdom

Ecuador

France

Spain

Spain

Spain

Brazil

South Africa

Poland

Spain

Poland

Tunisia

South Africa

South Africa

Hong Kong Singapore

Singapore

South Africa

Australia Austria Cyprus Estonia France

Estonia Lithuania

Hong Kong

Ireland

Hong Kong

Ireland

Hong Kong

Ecuador

Brazil

Finland

Brazil Cyprus Poland

Estonia Lithuania

Poland

United States

United Kingdom

Brazil

Hong Kong

United Kingdom

Tunisia

Brazil Spain

Lithuania

Ecuador

Spain

Ecuador

Austria Germany

Tunisia

Spain

Ecuador

Ecuador

Ecuador

Austria Estonia Germany Lithuania Poland

Hong Kong

Germany

Ecuador

Austria

Ecuador

Spain

Ecuador

Germany

Ecuador

Ecuador

Tunisia

Brazil

South Africa

Ireland

Ecuador

Hong Kong

Spain

Ecuador Spain

Germany

Hong Kong

Ecuador

Ecuador

Spain

Ecuador

Hong Kong

Ecuador

United Kingdom

South Africa United Kingdom

Ireland

New Zealand United Kingdom

United Kingdom

Estonia

Ecuador

Spain

Tunisia

Ecuador

Hong Kong

New Zealand

Austria

Poland

Poland

South Africa

Hong Kong

IBU

United States

Ecuador

Ecuador Spain United Kingdom

South Africa Tunisia

South Africa

Germany

Spain

Estonia Germany Lithuania Poland

Lithuania

Spain

Ecuador Hong Kong Lithuania Poland Singapore

France

Germany

Ecuador

Brazil

Brazil

Lithuania

Ireland United Kingdom

Ecuador

Ecuador New Zealand South Africa

Germany

Spain

Spain

United Kingdom

South Africa United Kingdom

Brazil

Poland

Italy

Estonia Finland Lithuania Poland

Estonia South Africa

Austria Estonia Finland Lithuania

South Africa

Poland

Austria

Poland

Tunisia

France

Tunisia

Poland

Brazil

Lithuania Poland

Ecuador

Ecuador

Poland

Poland

Hong Kong

Finland

Germany Spain

Ecuador

South Africa

Hong Kong

United Kingdom

Estonia Lithuania

Spain

Finland

Poland

Germany

Estonia Germany Lithuania

Ecuador

Finland

Lithuania

Brazil

Ecuador

Poland

Finland

Ecuador

Estonia

Hong Kong

Hong Kong

South Africa

Hong Kong

Estonia

Ecuador

Hong Kong

Ecuador

Hong Kong

Spain

Hong Kong

Poland

Hong Kong

South Africa

Spain

Poland

Lithuania

South Africa

Tunisia

Brazil

Ireland

Poland

Ireland

Tunisia

Brazil Canada Ecuador United States

Ecuador

Austria Spain Tunisia

Estonia United States

Germany

Hong Kong

South Africa

Spain

Spain

Tunisia

Brazil

Spain

Canada

Austria France

South Africa

Austria Cyprus Estonia France Germany

Lithuania

Brazil

Spain

Tunisia

Singapore

Austria Estonia Finland France Hong Kong

Germany

Cyprus Hong Kong Singapore

Germany

Ireland United Kingdom

Spain

Spain

Hong Kong

Ecuador

South Africa

Ecuador

Ecuador

Ecuador

Ecuador

South Africa

Ecuador

Cyprus

Cyprus Hong Kong

Hong Kong

Ecuador

Ecuador

Spain

Germany

France Hong Kong Poland Singapore

Italy Netherlands

France

Hong Kong

Ecuador

Ecuador

Brazil

Ecuador

Austria

Germany

Hong Kong

Lithuania

France Tunisia

Brazil

Hong Kong

Tunisia

Hong Kong Singapore

Ibuprofen is also found within below combination drugs:

ADOBIL , ADVIL COLD & FLU , ADVIL COLD & SINUS CONVENIENCE PACK , ADVIL COLD & SINUS LIQUI-GELS , ADVIL COLD & SINUS PLUS , ADVIL COLD AND SINUS , ADVIL COLD AND SINUS DAYTIME , ADVIL COLD AND SINUS NIGHTTIME , ADVIL COLD, COUGH & FLU NIGHTTIME , ADVIL COLD, SINUS & FLU EXTRA STRENGTH , ADVIL DAY/NIGHT CONVENIENCE PACK , ADVIL NIGHTTIME , ADVIL ZATOKI , ANALGION FEM , ANTARENE CODEINE , APAP INTENSE , APSELAN PLUS , ARDINEX , ASTEFOR , BERALFENO , BI-GESIC , BISOLFREN , BOXAGRIPPAL , BRUFEN PLUS , BRUPRO COLD & FLU , BUPREX FEM , BUPREX FLEX , BUPREX MIGRA , BUPREX RELAX , BURANA-C , BYFONEN PLUS , CAFIBEXX , CETAFLUX AC , CLIPTOL , COMBOGESIC , DAIKOL , DEMAZIN COLD AND FLU , DENTOPAIN , DENTOPAIN FORTE , DIP RILIF , DOLERIN , DOLFEMIN DUAL , DOLORFLU , DOLORGESIC RELAX , DOLORPAN FORTE , DOLOSTOP PLUS , DOLVEN RHUME , DOVIR , DUEXIS , DUOMAX , DUOPAS , DUORIN , EASOLIEF DUO , ECE , EFFICOL PLUS , FEBERTT MIGRA , FEBRILEK , FEMMEXTRA , FINALIN FEM , FLUKIT PLUS , FLUSTAD , FLUTURAN , GEN-PAYNE , GRIPADUO , IBALGIN SPORT , IBIZOL , IBU-SPA , IBUCOD , IBUCODE PLUS , IBUCOMP , IBUDOL MIGRAX , IBUFIX , IBUFLASH MIGRAN , IBUM GRIP , IBUM ZATOKI , IBUMAX COLD & FLU , IBUMAX-C , IBUMEDICA , IBUMENT , IBUMOL , IBUMOL FORTE , IBUPAIN , IBUPAIN FORTE , IBUPAR FORTE , IBUPAXX , IBURHUME , IBUSIN , IBUXX MIGRA , ILOXEN , INFEX , IPRAFEINE , KIDOFEN DUO , LOTEM , LUFTAFEM , MAXIGESIC , MAXIGESIC PE , MEDIX SINUS PE , METAFEN , METAFENEX , MIGRAFEINA-ER , MIGRAFLASH , MIGRALFEN , MIGRAMIL , MIGRASTOP , MODAFEN EXTRA GRIP , MODAFEN GRIP , MOLAR-EX , MOTRIN PLATINUM , MOVIPREN , MUCOCOLD , MULTIDOL ULTRA , MYBUCOD , MYBULEN , MYORIL , MYPAID , MYPRODOL , NEOBRUFEN CON CODEINA , NIMPAS , NORAVER G , NORAVER G FAST , NORMOTEMP ODO , NUROFEN COLD & FLU PE , NUROFEN COLD AND FLU , NUROFEN COLD AND FLU RELIEF , NUROFEN DAY AND NIGHT , NUROFEN PLUS , NUROFEN RHUME , NUROFEN SINUS AND PAIN , NUROFEN ULTIMA , NUROFEN ZATOKI , NUROMOL , PANADO PLUS , PARACOLIC , PARAFENGEN , PARALGEN PLUS , PASSIF FORTE , PHARMAFREN , PROFINAL MIGRA , PROFINAL RELAX , RHINADVIL RHUME , ROBAX PLATINUM , RUFEN FORTE , SALVARINA , SOLPADEINE MIGRAINE , SPIDUFEN , SUDAFED SINUS PAIN RELIEF , SUDAFED SINUS PRESSURE & PAIN , TASIFEN MIGRANA , TASIFEN MUSCULAR , TENSORELAX FORTE , TENSOVID PLUS , TENVALIN FLU , TERMO DOLOGRIP , THOMADUO , TIOCOLFEN , TIORELAX , TONUFEN , TUOAN , WICK DAYMED DUO , ZATOTABS

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Structured Product Monograph (SPM)
CA
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

WK2XYI10QM - IBUPROFEN

CAS registry number

15687-27-1 - Ibuprofen

SNOMED-CT

387207008 - Ibuprofen (substance)